4/16/2023, 6:49 AM (Source: TeleTrader)
more TeleTrader news

Merck reportedly in talks to buy Prometheus Biosciences

Merck & Co. is in late-stage negotiations on buying Prometheus Biosciences Inc, the Wall Street Journal reported on Sunday, citing people familiar with the matter.

According to the sources, the deal is still not certain to be struck, but if it is, it could be announced later in the day.

Prometheus develops immune disease treatments, including those for ulcerative colitis and Crohn’s disease, but still doesn't have any approved drugs.

Baha Breaking News (BBN) / NP